GA-002

N/A

Report date: 2026/03/12 20:00:16

Base Information

Drug NameGA-002
Drug Alias NameGA-002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionBifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase modulators
TargetsBifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesGenosera Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGenosera IncGenAns Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A